Xi Yin1, Qian Wang2, Ting Chen1, Junwei Niu1, Rui Ban1, Jiexiao Liu1, Yanling Mao1, Chuanqiang Pu1. 1. Department of Neurology, Chinese PLA General Hospital 28 Fuxing Road, Haidian District, Beijing 100853, China. 2. Department of Emergency, General Hospital of Chinese People's Armed Police Force 69 Yongding Road, Haidian District, Beijing 100039, China.
Abstract
OBJECTIVE: Dysferlin is a sarcolemmal protein that plays an important role in membrane repair by regulating vesicle fusion with the sarcolemma. Mutations in the dysferlin gene (DYSF) lead to multiple clinical phenotypes, including Miyoshi myopathy (MM), limb girdle muscular dystrophy type 2B (LGMD 2B), and distal myopathy with anterior tibial onset (DMAT). Patients with dysferlinopathy also show muscle inflammation, which often leads to a misdiagnosis as inflammatory myopathy. In this study, we examined and analyzed the dyferlinopathy-associated immunological features. METHODS: Comparative immunohistochemical analysis of inflammatory cell infiltration, and muscle expression of MHC-I and C5b-9 was performed using muscle biopsy samples from 14 patients with dysferlinopathy, 7 patients with polymyositis, and 8 patients with either Duchenne muscular dystrophy or Becker muscular dystrophy (DMD/BMD). RESULTS: Immunohistochemical analysis revealed positive staining for immune response-related CD4+ cells, macrophages, MHC-I and C5b-9 in dysferlinopathy, which is in a different mode of polymyositis and DMD/BMD. CONCLUSION: These results demonstrated the involvement of immune factors in the pathogenesis of dysferlinopathy.
OBJECTIVE:Dysferlin is a sarcolemmal protein that plays an important role in membrane repair by regulating vesicle fusion with the sarcolemma. Mutations in the dysferlin gene (DYSF) lead to multiple clinical phenotypes, including Miyoshi myopathy (MM), limb girdle muscular dystrophy type 2B (LGMD 2B), and distal myopathy with anterior tibial onset (DMAT). Patients with dysferlinopathy also show muscle inflammation, which often leads to a misdiagnosis as inflammatory myopathy. In this study, we examined and analyzed the dyferlinopathy-associated immunological features. METHODS: Comparative immunohistochemical analysis of inflammatory cell infiltration, and muscle expression of MHC-I and C5b-9 was performed using muscle biopsy samples from 14 patients with dysferlinopathy, 7 patients with polymyositis, and 8 patients with either Duchenne muscular dystrophy or Becker muscular dystrophy (DMD/BMD). RESULTS: Immunohistochemical analysis revealed positive staining for immune response-related CD4+ cells, macrophages, MHC-I and C5b-9 in dysferlinopathy, which is in a different mode of polymyositis and DMD/BMD. CONCLUSION: These results demonstrated the involvement of immune factors in the pathogenesis of dysferlinopathy.
Authors: I Illa; C Serrano-Munuera; E Gallardo; A Lasa; R Rojas-García; J Palmer; P Gallano; M Baiget; C Matsuda; R H Brown Journal: Ann Neurol Date: 2001-01 Impact factor: 10.422
Authors: Renzhi Han; Ellie M Frett; Jennifer R Levy; Erik P Rader; John D Lueck; Dimple Bansal; Steven A Moore; Rainer Ng; Daniel Beltrán-Valero de Bernabé; John A Faulkner; Kevin P Campbell Journal: J Clin Invest Date: 2010-11-08 Impact factor: 14.808
Authors: J Liu; M Aoki; I Illa; C Wu; M Fardeau; C Angelini; C Serrano; J A Urtizberea; F Hentati; M B Hamida; S Bohlega; E J Culper; A A Amato; K Bossie; J Oeltjen; K Bejaoui; D McKenna-Yasek; B A Hosler; E Schurr; K Arahata; P J de Jong; R H Brown Journal: Nat Genet Date: 1998-09 Impact factor: 38.330
Authors: Alyssa F Collier; Jessica Gumerson; Kimmo Lehtimäki; Jukka Puoliväli; Jace W Jones; Maureen A Kane; Sankeerth Manne; Andrea O'Neill; Hillarie P Windish; Toni Ahtoniemi; Bradley A Williams; Douglas E Albrecht; Robert J Bloch Journal: J Pharmacol Exp Ther Date: 2017-12-28 Impact factor: 4.030
Authors: S A Durward-Akhurst; C J Finno; N Barnes; J Shivers; L T Guo; G D Shelton; S J Valberg Journal: J Vet Intern Med Date: 2016-06-28 Impact factor: 3.333
Authors: Maher Kurdi; Aysha Alshareef; Ahmed K Bamaga; Zahir T Fadel; Moafaq S Alrawaili; Sahar Hakamy; Fawaz Mohamed; Ahmad R Abuzinadah; Bassam M J Addas; Nadeem Shafique Butt Journal: Degener Neurol Neuromuscul Dis Date: 2021-12-30